SPAC JATT II Acquisition prices $60 million IPO, targeting biotech and life sciences IPO Overview JATT II Acquisition, a blank check company targeting biotechs and life sciences businesses, raised $60 million by offering 6 million shares at $10. The company... Read more
Categories
- Funds and Etfs (81)
- Good stocks (82)
- investment (22)
- IPO News (306)
- Stock Analysis (29)
- Stock Books (3)
- Stock Knowledge (31)
- Stock News (29)
- Uncategorized (4)